July 25th, 2025 - Press release
Researchers from the Hospital del Mar Research Institute and Yale University, in the United States, have demonstrated how the action of certain genes on precursor cells of brain formation can cause alterations linked to cortical malformations but also to the origin of neuropsychiatric diseases such as autism or bipolar disorder.
The study, published in Nature Communications, is the first of its kind. It has been able to simulate the function of a list of nearly 3,000 genes linked to these pathologies during human brain development.
The work opens a window to understand the origin of these diseases and to develop treatment opportunities through gene therapy.
July 16, 2025 - Press release
These molecules act as small building blocks that regulate the cellular response by switching certain internal signals on or off.
This is the conclusion of an international study led by the Hospital del Mar Research Institute, published in the journal Nature Communications.
The findings may help develop more precise drugs to treat various diseases more effectively, while avoiding side effects.
May 27th, 2025 - Press release
A joint project between the three research institutions has been selected for funding by the XPRIZE Foundation of the United States. It will receive $250,000 to demonstrate that it is possible to extend human healthy lifespan.
The VITA project proposes combining two existing molecules and a multimodal lifestyle intervention to extend quality of life during aging.
The team formed by the three institutions now has one year to provide the first preliminary results and move on to a new stage of the awards, where the efficacy of the proposed new therapy will be assessed.
February 20th, 2025 - Press release
Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts, published in Nature Communications.
The study has significant relevance, impacting the management of bladder cancer patients. Machine learning tools enabled the identification of key variables for the success of immunotherapy treatment.
This innovative methodology has allowed researchers to pinpoint which tumor subtypes respond best to immunotherapy.
October 28th, 2022 - Press release
This is a study cohort comprising 200,000 people, which will be used to study and improve the health of the Spanish population. Dr. Jordi Alonso, head of the Health Services Research Group at the IMIM-Hospital del Mar, is a member of the project's executive committee, which has just completed its first year of work.
June 15 th, 2021 - Press release
On June 15th and 16th, the STOPSTORM consortium coordinated by the UMC Utrecht with the IMIM and Hospital del Mar's participation, met virtually to discuss early project progress. The project, which officially started on May 1st, will begin researching the use of radiotherapy in treating cardiac arrhythmias. Patients who suffer from ventricular tachycardia (fibrillation of the ventricles) are often treated with medication and/or implantation of an ICD, a defibrillator that corrects a rapid heart rate with an electric shock. In cases of persistent arrhythmias that do not respond adequately to regular therapy, patients may undergo invasive catheter ablation.
July 14th 2020 - Press release
The results of the study, published in Nature Methods, may facilitate the development of new drugs related to diseases such as cancer and Alzheimer's. The new tool provides access to a large number of atomic-level simulations, the most basic, of the behaviour of a crucial element in almost all human physiological responses. This work is the result of a study by a consortium of international research centres led by scientists at the Hospital del Mar Medical Research Institute, in collaboration with Pompeu Fabra University and the Paul Scherrer Institute in Switzerland, and with the support of the Autonomous University of Barcelona.
June 3rd 2020 - Press release
This is a pioneering Data Analytics project in Spain, which will enable us to increase our knowledge of the evolution of COVID-19 and its interaction with patients with other pathologies based on the analysis of discharge reports. The initiative is the result of collaboration between Hospital del Mar, the technology company Bismart and Ferrer Laboratory and uses the artificial intelligence tool Bismart Folksonomy. In less than a month, a project has been launched with more than 34,000 hospital and emergency room discharges, 2,700 of which correspond to COVID-19 patients. This will allow an in-depth analysis of their evolution and the relationship of the infection with other basic pathologies.
March 9th 2020 - Press release
Researchers at the Hospital del Mar Institute for Medical Research have led a study demonstrating how the relationship between two molecules plays a key role in the generation of these cells. The work has been published in The EMBO Journal.
February 14th 2020 - Press release
A joint study between Hospital del Mar, IDIBELL, the University of Helsinki and the Spanish National Research Council funded by La Marató de TV3 tries to analyze the effects of music therapy (musical learning) once patients have finished hospital rehabilitation and are in a chronic state of the disease. To do this, they designed a keyboard linked to a smart tablet that allows the participants of the study to do their exercises at home and learn gradually in an established manner. An earlier study of the same group shows that musical therapy, like other therapies, has similar effects in motor rehabilitation for patients who have suffered a stroke, having a strong impact in mood improvement and quality of life.
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2026 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
